Transcatheter Closure of LCx to Coronary Sinus Fistula In this #JACCCR case you will find: 🧩multimodality diagnostic approach 🛠️procedural planning 🧶role & technical challenges of coils Read the case from @DL_Feldman @jcecharte @MatteoSturlaM et al. 🔗 https://t.co/SI9dSSG4XY

@EdwinHoMD @CardioMDPhD @AndreaScotti21 @MatteoSturlaM @jcecharte @analyzeF @GilbertTangMD @MonteHeart @MontefioreNYC

🫀How would you treat a ventricular PSA in a high-risk patient? In our @JACCJournals CS, we present a novel transcatheter strategy combining closure devices with bare-metal coils for effective PSA exclusion. 👉Check out our experience: 📖 https://t.co/r7eBEmRDkj @azeemlatib

Welcome to our July 2 issue of #JACCCaseReports @JACCJournals! See our articles with links below. https://t.co/4acX848Orp Full PDF here: https://t.co/xRrhwzGILZ Video summary here: https://t.co/EYSyUQB1Hy Thank you our Associate Editor @sarano_maurice for his Editor’s Page:

Congratulations to the 5 exceptional young Interventional Cardiologists who received their #EAPCI Grants in the Main Arena at #EuroPCR 2025 The future of our profession is bright

77y/o man presented to the ED with angina that had started 24 hours prior. His #ECG was unremarkable, and laboratory tests showed a mild elevation in cardiac troponin I (3.72 ng/mL). What's the diagnosis? 🤔 🔗 https://t.co/SYgAUnTdT6 #JACCCaseReports #PCI @azeemlatib

Check this complex case of LCx Pseudoaneurysm 💡Good learning points for Complication Diagnosis, Management, and Prevention! 🔗 https://t.co/pKboazCXc4 @Antonellamillin @MatteoSturlaM @azeemlatib @MonteHeart @GilbertTangMD @JACCJournals @MontefioreNYC @EinsteinMed

🚨 Complication post-PCI! A rapidly expanding LCx pseudoaneurysm 💥 👨‍⚕️ See how we managed it at @MonteHeart : 📖 https://t.co/v5wWNnoird @azeemlatib @AndreaScotti21 @MatteoSturlaM #JACCCaseReports @JACCJournals

🌐Burden of Valvular Heart Diseases in a Diverse Population: The Bronx Valve Registry 🎯There is a clear need for more DIVERSE participation in clinical trials 🔗 https://t.co/WgcecX6DAS @azeemlatib @MatteoMSturla @jcecharte @MonteHeart @MontefioreNYC @EinsteinMed @JAHA_AHA

How does platypnea-orthodeoxia syndrome present? Read @MonteHeart team’s newly published case report on therapeutic PFO-closure in a 92-year-old patient to find out! @AndreaScotti21 @MatteoSturlaM @Antonellamillin @EdwinHoMD @azeemlatib @montefioreIM https://t.co/zhUGG8nqLA

Immensely grateful to #EAPCI for offering me the opportunity to attend the @SCAI #FellowsCourse. And a big thank you to the @SCAI course directors for all the educational and insightful sessions! An excellent opportunity to learn and network with IC fellows from around the world

💫Check our last paper from @MonteHeart based on Race/Ethnicity disparities in severe TR @azeemlatib @AndreaScotti21 @guilbon @jtorrado_arrosa @MatteoSturlaM 🎯 Black/Hispanic ➡️advanced TR disease 🎯 A-STR ⬆️ in White ➡️ Black experienced ⬆️HF 🏥 📎 https://t.co/WZJxebkFhz

Thrilled to be at the @SCAI fellow course in #Miami, sharing this amazing experience with my fellow Italian colleagues @MrcTsl @MiriamComp21447 @GraziellaPompei . Huge thanks to @sicigise and #giseyoung for making it all possible! #SCAIfellows

🌐 Shoutout to the international #InterventionalCardiology fellows who have travelled from over 23 countries around the world to join us here in #Miami at #SCAIFellows.

💥Screening for TTVI: A Call for Innovation to Close the Eligibility Gap @JACCJournals 🌐Eligibility for T-TEER vs. TTVR in a real-world setting 🔗 Editorial https://t.co/AqKARkrY2g @azeemlatib @MonteHeart @MontefioreNYC @EinsteinMed #CardioED #MedEd

Check out our case series of hemolytic anemia post TAVR. We demonstrate a feasible and effective percutaneous approach for these patients. Great team effort @AndreaScotti21 @Antonellamillin @jcecharte @guilbon @andrea_mignatti @m_assafin @CardioMDPhD @EdwinHoMD @azeemlatib

Very educative & nicely illustrated series on #TAVR #PVL + hemolysis by @MonteHeart team in @JACCJournals #JACCCR 🎯Distinct clinical presentations ➡️Plug based closure ➡️Resolution of hemolysis at f/u 🔗: https://t.co/vbc6497i3Z

New technologies for transcatheter interventions🌟@azeemlatib @nickaram 🎯65 y/o with severe MR ✅ TMVR with Intrepid @nicolo_piazza 🎯75 y/o with severe TR ✅ TTVR with Lux-Valve @RodrigoEstvez1 🎯64 y/o and severe AS ✅ FIH TAVR with @AbbottCardio @bapat_savrtavr

GISE YOUNG SESSION at #GISE45 Focus on clinical case reports To have your case report published: 📍Choose a “clickbait” title! 📍select the right journal for your specific case ✍️ write the case properly with clear educational messages …good luck!🤞@sicigise

🚨 Exciting findings at #NYValves2024! Triplace by @AndreaScotti21 🎯 High AV Block in 15% of patients at 1 month after TTVR; 12.4% new PPM 🎯 Most HAVBs (89%) within 1 week from TTVR 🎯 Baseline LBBB/LAFB/LPFB confers a high risk of HAVB Key points: 🔸 Pre-TTVR risk